Ownership provisions were under the spotlight this week, plus there were updates on the Active Script List model, real-time monitoring and active ingredient prescribing
This week we heard that active ingredient prescribing continues to experience teething problems, with practitioners urged to double-check scripts. The Department of Health has confirmed that work is still underway to correct issues with software providers regarding the changes.
A Department of Health digital health expert predicted that nationwide real time monitoring program rollout is looking likely to happen by the end of the year. All states and territories have signed up for the program but are at “various stages of integration and technical build of their systems, and of enacting necessary legislative changes to allow them to share this data”.
Meanwhile we heard that the national launch of the e-prescribing active script list (ASL) database is expected “soon”, which will provide another option for pharmacies and patients following the launch of the token model last year.
The Victorian Pharmacy Authority (VPA) spoke out about recent media reports and statements claiming certain entities own hundreds of pharmacies.
“These claims are not supported by evidence,” said VPA chair David McConville.
“The Authority will continue to ensure that legislated ownership provisions are upheld. This is supported by comprehensive licence application assessment processes, pharmacy ownership audits and franchise reviews.”
We heard that the pandemic response sub-register is set to close for pharmacists on 5 April, 12 months after it was established in response to COVID-19.
Pharmacies have been added to watchlists in both Queensland and NSW, as authorities hope the lockdown could be lifted before Easter. Queensland Health has updated the list of locations visited by people infected with COVID-19.
The International Pharmaceutical Federation (FIP) announced the theme of World Pharmacists Day for 25 September 2021: “Pharmacy: Always trusted for your health”.
We heard from experts that Australia is falling behind in tracking and tracing medicines through the supply chain.
And the TGA launched a consultation into issues around medicine supply and shortages.